MIDDLE EAST AND AFRICA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Middle East and African Self-Monitoring Blood Glucose Devices Market are Segmented Into Components (glucometer Devices, Test Strips, And Lancets) and Geography (Egypt, Iran, Saudi Arabia, Oman, South Africa, And the Rest of the Middle East and Africa). The Report Offers the Value (in USD) and Volume (in Units) for the Above Segments.

MEA Self-monitoring Blood Glucose Devices Market Size

Compare market size and growth of MEA Self-monitoring Blood Glucose Devices Market with other markets in Healthcare Industry

MEA Self-monitoring Blood Glucose Devices Market Analysis

The MEA Self-monitoring Blood Glucose Devices Market size is estimated at USD 267.78 million in 2025, and is expected to reach USD 354.81 million by 2030, at a CAGR of 5.79% during the forecast period (2025-2030).

The Middle East and African region had witnessed an alarming increase in the prevalence of diabetes, in recent years, the rate of diabetes is at an all-time high, mainly due to lifestyle changes. Diabetes is associated with many health complications. 

Patients with diabetes require many corrections throughout the day to maintain nominal blood glucose levels, such as administering additional insulin or ingesting additional carbohydrates by monitoring their blood glucose levels. Diabetes poses an emerging healthcare burden across the region.

Governments in the Middle East identified the threat of diabetes and started to respond with various policies, initiatives, and programs. Six out of 15 countries in this region still do not contain a national operational action policy for diabetes. 

Many countries still do not include a national strategy to reduce overweight, obesity, and physical inactivity, which are important risk factors for diabetes. Most counties fully implemented national diabetes treatment guidelines. However, constant measures are being taken to minimize diabetic complications. Therefore, the studied market is anticipated to grow due to the factors above.

Owing to the aforementioned factors the studied market is anticipated to witness growth over the analysis period.

MEA Self-monitoring Blood Glucose Devices Industry Overview

The Middle East and African self-monitoring blood glucose devices market is fragmented, with few major manufacturers boasting a global market presence. In contrast, the remaining manufacturers are confined to other local regions.

MEA Self-monitoring Blood Glucose Devices Market Leaders

  1. Platinum Equity (LifeScan)

  2. Abbott Diabetes Care

  3. Ascensia Diabetes Care

  4. ARKRAY Inc.

  5. Roche Diabetes Care

  6. *Disclaimer: Major Players sorted in no particular order
Need More Details on Market Players and Competiters?
Download PDF

MEA Self-monitoring Blood Glucose Devices Market News

  • October 2023: the World Health Organization (WHO) unveiled an updated list of essential diagnostics, which included new guidelines for personal use glucose meters. The WHO advised incorporating personal use glucose monitoring devices into the existing medical recommendations for diabetes.
  • June 2022: LifeScan announced that the peer-reviewed journal Diabetes Technology and Therapeutics published real-world evidence of improved glycemic control in people with diabetes using a Bluetooth-connected Blood Glucose Meter with Mobile Diabetes Management Application. It can be done using the OneTouch Reveal mobile app with the OneTouch Verio Reflect meter synced via Bluetooth wireless technology. It could support improved glycemic control for people with diabetes.

MEA Self-monitoring Blood Glucose Devices Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
  • 4.3 Market Restraints
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products and Services
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION

  • 5.1 Component
    • 5.1.1 Glucometer Devices
    • 5.1.2 Test Strips
    • 5.1.3 Lancets
  • 5.2 Geography
    • 5.2.1 Egypt
    • 5.2.2 Iran
    • 5.2.3 Saudi Arabia
    • 5.2.4 Oman
    • 5.2.5 South Africa
    • 5.2.6 Rest of Middle East and Africa

6. MARKET INDICATORS

  • 6.1 Type-1 Diabetes population
  • 6.2 Type-2 Diabetes population

7. COMPETITIVE LANDSCAPE

  • 7.1 Company Profiles
    • 7.1.1 Abbott Diabetes Care
    • 7.1.2 Roche Diabetes Care
    • 7.1.3 Platinum Equity (LifeScan)
    • 7.1.4 Arkray
    • 7.1.5 Ascensia Diabetes Care
    • 7.1.6 Agamatrix Inc.
    • 7.1.7 Medisana
    • 7.1.8 Trivida
    • 7.1.9 I-Sens
  • *List Not Exhaustive

8. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
*The report covers a segment-wise breakdown (Value and Volume) for all the countries covered under Table of Contents **Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

MEA Self-monitoring Blood Glucose Devices Industry Segmentation

Self-monitoring blood glucose devices is an important aid for diabetic patients. Patients with diabetes can measure their blood glucose to detect hypoglycemia, adjust insulin doses as needed, and establish the response to nutrition and pharmacotherapy. The middle east and african self-monitoring blood glucose devices market are segmented into components and geography. The report offers the value (in usd) and volume (in units) for the above segments. 

Component Glucometer Devices
Test Strips
Lancets
Geography Egypt
Iran
Saudi Arabia
Oman
South Africa
Rest of Middle East and Africa
Need A Different Region or Segment?
Customize Now

MEA Self-monitoring Blood Glucose Devices Market Research FAQs

How big is the MEA Self-monitoring Blood Glucose Devices Market?

The MEA Self-monitoring Blood Glucose Devices Market size is expected to reach USD 267.78 million in 2025 and grow at a CAGR of 5.79% to reach USD 354.81 million by 2030.

What is the current MEA Self-monitoring Blood Glucose Devices Market size?

In 2025, the MEA Self-monitoring Blood Glucose Devices Market size is expected to reach USD 267.78 million.

Who are the key players in MEA Self-monitoring Blood Glucose Devices Market?

Platinum Equity (LifeScan), Abbott Diabetes Care, Ascensia Diabetes Care, ARKRAY Inc. and Roche Diabetes Care are the major companies operating in the MEA Self-monitoring Blood Glucose Devices Market.

What years does this MEA Self-monitoring Blood Glucose Devices Market cover, and what was the market size in 2024?

In 2024, the MEA Self-monitoring Blood Glucose Devices Market size was estimated at USD 252.28 million. The report covers the MEA Self-monitoring Blood Glucose Devices Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the MEA Self-monitoring Blood Glucose Devices Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

MEA Self-monitoring Blood Glucose Devices Industry Report

Statistics for the 2025 MEA Self-monitoring Blood Glucose Devices market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. MEA Self-monitoring Blood Glucose Devices analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.

MEA Self-monitoring Blood Glucose Devices Market Report Snapshots

MIDDLE EAST AND AFRICA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)